aSamples were obtained from the following clinical cohorts (see Methods): CAPRISA: the CAPRISA 004 Study/TRAPS [32]; FHI/Uganda and FHI/Zimbabwe: the FHI360 Hormonal Contraception and HIV (HC-HIV) Tri
Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organisation for HIV infected persons. However, once HIV infected patients have commenced anti-retroviral treatment (ART), the benefi
